Summary of Significant Accounting Policies (Tables)
|
12 Months Ended |
Dec. 31, 2016 |
Accounting Policies [Abstract] |
|
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
As of December 31,
2016 |
|
Description
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Fair Value |
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$ |
9,456 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
9,456 |
|
Commercial paper
|
|
|
— |
|
|
|
599 |
|
|
|
— |
|
|
|
599 |
|
Corporate debt securities
|
|
|
— |
|
|
|
500 |
|
|
|
— |
|
|
|
500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents
|
|
|
9,456 |
|
|
|
1,099 |
|
|
|
— |
|
|
|
10,555 |
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper
|
|
|
— |
|
|
|
4,295 |
|
|
|
— |
|
|
|
4,295 |
|
Corporate debt securities
|
|
|
— |
|
|
|
2,204 |
|
|
|
— |
|
|
|
2,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term investments
|
|
|
— |
|
|
|
6,499 |
|
|
|
— |
|
|
|
6,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets measured at fair value
|
|
$ |
9,456 |
|
|
$ |
7,598 |
|
|
$ |
— |
|
|
$ |
17,054 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liability
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,145 |
|
|
$ |
1,145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities measured at fair value
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,145 |
|
|
$ |
1,145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
As of December 31, 2015 |
|
Description
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Fair Value |
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$ |
6,942 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,942 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents
|
|
$ |
6,942 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,942 |
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper
|
|
|
— |
|
|
|
5,992 |
|
|
|
— |
|
|
|
5,992 |
|
Government debt securities
|
|
|
— |
|
|
|
1,507 |
|
|
|
— |
|
|
|
1,507 |
|
Corporate debt securities
|
|
|
— |
|
|
|
21,654 |
|
|
|
— |
|
|
|
21,654 |
|
Asset-backed securities
|
|
|
— |
|
|
|
4,621 |
|
|
|
— |
|
|
|
4,621 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term investments
|
|
|
— |
|
|
|
33,774 |
|
|
|
— |
|
|
|
33,774 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets measured at fair value
|
|
$ |
6,942 |
|
|
$ |
33,774 |
|
|
$ |
— |
|
|
$ |
40,716 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liability
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,220 |
|
|
$ |
1,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities measured at fair value
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,220 |
|
|
$ |
1,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of Changes in Fair Value of Liabilities |
The following tables set forth a summary of the changes in the fair
value of our liabilities measured using Level 3 inputs (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
For the Twelve
Months Ended December |
|
|
|
2016 |
|
|
2015 |
|
Balance, beginning of period
|
|
$ |
1,220 |
|
|
$ |
13,596 |
|
Issuance of financial instrument
|
|
|
— |
|
|
|
258 |
|
Change in fair value
|
|
|
(75 |
) |
|
|
(11,121 |
) |
Settlement of financial instrument
|
|
|
— |
|
|
|
(1,513 |
) |
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
$ |
1,145 |
|
|
$ |
1,220 |
|
|
|
|
|
|
|
|
|
|
|
Computation of Basic and Diluted Net Loss per Share |
The following table sets forth the computation of basic and diluted
net loss per share (in thousands, except share and per share
amounts):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2016 |
|
|
2015 |
|
Numerator:
|
|
|
|
|
|
|
|
|
Net loss allocated to common stock—basic
|
|
$ |
(26,671 |
) |
|
$ |
(15,529 |
) |
Adjustment for revaluation of warrants
|
|
|
— |
|
|
|
(94 |
) |
|
|
|
|
|
|
|
|
|
Net loss allocated to common stock—diluted
|
|
$ |
(26,671 |
) |
|
$ |
(15,623 |
) |
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
Weighted average number of common stock shares
outstanding—basic
|
|
|
23,447,003 |
|
|
|
18,900,473 |
|
Dilutive common stock warrants
|
|
|
— |
|
|
|
16,740 |
|
|
|
|
|
|
|
|
|
|
Weighted average number of common stock shares
outstanding—diluted
|
|
|
23,447,003 |
|
|
|
18,917,213 |
|
Net loss per share—basic
|
|
$ |
(1.14 |
) |
|
$ |
(0.82 |
) |
|
|
|
|
|
|
|
|
|
Net loss per share—diluted
|
|
$ |
(1.14 |
) |
|
$ |
(0.83 |
) |
|
|
|
|
|
|
|
|
|
|
Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss per Share |
The following table shows the total outstanding securities
considered anti-dilutive and therefore excluded from the
computation of diluted net loss per share (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended
December 31, |
|
|
|
2016 |
|
|
2015 |
|
Common stock warrants
|
|
|
1,667 |
|
|
|
1,553 |
|
Common stock options
|
|
|
2,394 |
|
|
|
1,804 |
|
Performance-based stock options
|
|
|
327 |
|
|
|
— |
|
Incentive awards
|
|
|
239 |
|
|
|
245 |
|
|
|
|
|
|
|
|
|
|
|
|
|
4,627 |
|
|
|
3,602 |
|
|
|
|
|
|
|
|
|
|
|